Jane Street Group, LLC Opgen Inc Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.12 - $62.0 $60 - $31,248	-504 Reduced 2.54%	19,309 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.39 - $78.8 $7,727 - $1.56 Million	19,813 New	19,813 $6,000
Q2 2022 Aug 16, 2022	SELL	$0.32 - $0.79 $9,301 - $22,962	-29,066 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.72 - $1.11 $11,866 - $18,293	16,481 Added 130.96%	29,066 $22,000
Q4 2021 Feb 15, 2022	BUY	$1.0 - $2.94 $12,585 - $36,999	12,585 New	12,585 $13,000
Q2 2021 Aug 16, 2021	SELL	$1.95 - $2.8 $42,829 - $61,499	-21,964 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$1.8 - $3.55 $39,535 - $77,972	21,964 New	21,964 $55,000
Q2 2020 Aug 17, 2020	SELL	$1.88 - $2.59 $26,914 - $37,078	-14,316 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.14 - $4.04 $16,320 - $57,836	14,316 New	14,316 $37,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.